Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cerus Corp (CERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cerus Corp 2550 STANWELL DRIVE CONCORD CA 94520 USA

P: 925-288-6000 F: 925-288-6001

Description:

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.

Key Statistics

Overview:

Market Capitalization, $K 987,518
Shares Outstanding, K 133,810
Annual Sales, $ 51,330 K
Annual Net Income, $ -60,590 K
Last Quarter Sales, $ 19,470 K
Last Quarter Net Income, $ -13,280 K
36-Month Beta 1.60
% of Insider Shareholders 6.80%
% of Institutional Shareholders 59.77%

Growth:

1-Year Total Return 181.99%
3-Year Total Return 44.60%
5-Year Total Return 16.09%
5-Year Revenue Growth 39.52%
5-Year Earnings Growth -51.35%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 08/02/18
Next Earnings Date 11/01/18
Earnings Per Share ttm -0.43
EPS Growth vs. Prev Qtr 9.09%
EPS Growth vs. Prev Year 37.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

CERS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -17.20
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -82.60
Return-on-Assets (Before Tax) -42.37
Net Margin % -71.64
Debt/Equity 0.33
Price/Sales 19.24
Price/Cash Flow N/A
Price/Book 10.92
Book Value/Share -0.68
Interest Coverage -17.77
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar